Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A Randomized Trial Testing US Food and Drug Administration "Breakthrough" Language.
Krishnamurti T, Woloshin S, Schwartz LM, Fischhoff B. Krishnamurti T, et al. JAMA Intern Med. 2015 Nov;175(11):1856-8. doi: 10.1001/jamainternmed.2015.5355. JAMA Intern Med. 2015. PMID: 26390245 Clinical Trial. No abstract available.
Promotion of "low T" and the role of testosterone clinical trials--reply.
Schwartz LM, Woloshin S. Schwartz LM, et al. JAMA Intern Med. 2014 Feb 1;174(2):306-7. doi: 10.1001/jamainternmed.2013.12733. JAMA Intern Med. 2014. PMID: 24493615 No abstract available.
The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?
Woloshin S, Schwartz LM. Woloshin S, et al. JAMA Intern Med. 2014 Apr;174(4):615-9. doi: 10.1001/jamainternmed.2013.14629. JAMA Intern Med. 2014. PMID: 24515599
Drug treatment of obesity--reply.
Schwartz LM, Woloshin S. Schwartz LM, et al. JAMA Intern Med. 2014 Aug;174(8):1415-6. doi: 10.1001/jamainternmed.2014.1635. JAMA Intern Med. 2014. PMID: 25090180 No abstract available.
Cancer Center Advertising-Where Hope Meets Hype.
Schwartz LM, Woloshin S. Schwartz LM, et al. JAMA Intern Med. 2016 Aug 1;176(8):1068-70. doi: 10.1001/jamainternmed.2016.3278. JAMA Intern Med. 2016. PMID: 27399794 No abstract available.
312 results
Jump to page
Feedback